KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.28 $6.23 Friday, 26th Apr 2024 MBRX stock ended at $4.63. This is 7.47% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 11.16% from a day low at $4.41 to a day high of $4.90.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Apr 26, 2024 $4.50 $4.90 $4.41 $4.63 23 817
Apr 25, 2024 $4.30 $4.50 $4.28 $4.31 22 594
Apr 24, 2024 $4.46 $4.62 $4.35 $4.35 6 965
Apr 23, 2024 $4.29 $4.60 $4.29 $4.60 7 425
Apr 22, 2024 $4.78 $4.78 $4.30 $4.30 16 715
Apr 19, 2024 $4.59 $4.65 $4.40 $4.65 10 300
Apr 18, 2024 $4.49 $5.00 $4.41 $4.52 49 440
Apr 17, 2024 $4.32 $4.42 $4.28 $4.28 10 236
Apr 16, 2024 $4.55 $4.55 $4.28 $4.28 15 847
Apr 15, 2024 $4.60 $4.63 $4.32 $4.46 19 952
Apr 12, 2024 $4.82 $4.97 $4.54 $4.63 18 581
Apr 11, 2024 $5.06 $5.13 $4.68 $4.77 27 696
Apr 10, 2024 $5.69 $5.69 $4.81 $5.20 31 106
Apr 09, 2024 $5.09 $5.29 $5.02 $5.23 22 126
Apr 08, 2024 $5.12 $5.34 $5.00 $5.05 44 854
Apr 05, 2024 $4.96 $5.50 $4.96 $5.20 39 626
Apr 04, 2024 $5.29 $5.31 $5.10 $5.30 14 128
Apr 03, 2024 $5.33 $5.63 $5.09 $5.25 46 552
Apr 02, 2024 $5.70 $5.70 $5.18 $5.45 28 597
Apr 01, 2024 $5.79 $6.05 $5.67 $5.67 27 023
Mar 28, 2024 $5.63 $6.23 $5.18 $5.91 77 480
Mar 27, 2024 $4.80 $5.69 $4.75 $5.54 88 464
Mar 26, 2024 $4.95 $4.99 $4.34 $4.68 90 400
Mar 25, 2024 $6.00 $6.00 $4.65 $5.25 908 975
Mar 22, 2024 $5.56 $6.22 $5.32 $5.70 97 141
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT